Literature DB >> 12912791

Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy?

Nicole H Purcell, Jeffery D Molkentin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12912791     DOI: 10.1161/01.CIR.0000085362.40608.DD

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  A multivariate approach for integrating genome-wide expression data and biological knowledge.

Authors:  Sek Won Kong; William T Pu; Peter J Park
Journal:  Bioinformatics       Date:  2006-07-28       Impact factor: 6.937

Review 2.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

3.  Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.

Authors:  Xiuli Fang; Yajun Liu; Jing Lu; Huiqi Hong; Jing Yuan; Yuhong Zhang; Panxia Wang; Peiqing Liu; Jiantao Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-21       Impact factor: 3.000

4.  Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts.

Authors:  Sudhiranjan Gupta; Subha Sen
Journal:  J Mol Med (Berl)       Date:  2005-08-17       Impact factor: 4.599

5.  A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.

Authors:  Cosmo Damiano del Vescovo; Susanna Cotecchia; Dario Diviani
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

6.  Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.

Authors:  Hadi Javan; Amanda M Szucsik; Ling Li; Christin L Schaaf; Mohamed E Salama; Craig H Selzman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

7.  Is the lack of adiponectin associated with increased ER/SR stress and inflammation in the heart?

Authors:  Neeraja J Boddu; Sue Theus; Shoake Luo; Jeanne Y Wei; Gouri Ranganathan
Journal:  Adipocyte       Date:  2013-10-09       Impact factor: 4.534

Review 8.  The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophy.

Authors:  Todd R Harris; Ning Li; Nipanvan Chiamvimonvat; Bruce D Hammock
Journal:  Congest Heart Fail       Date:  2008 Jul-Aug

9.  Nuclear co-translocation of myotrophin and p65 stimulates myocyte growth. Regulation by myotrophin hairpin loops.

Authors:  Biswajit Das; Sudhiranjan Gupta; Amit Vasanji; Zhen Xu; Saurav Misra; Subha Sen
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

10.  Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner.

Authors:  Elangovan Vellaichamy; Subhankar Das; Umadevi Subramanian; Nobuyo Maeda; Kailash N Pandey
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.